4-((4,5-DIHYDRO-1H-IMIDAZOL-2-YL)METHYL)-2-HYDROXY-.BETA.,.BETA.,3,5-TETRAMETHYL-BENZENEETHANOL
UNII ND453C04TL
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-((4,5-dihydro-1h-imidazol-2-yl)methyl)-2-hydroxy-.beta.,.beta.,3,5-tetramethyl-benzeneethanol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ND453C04TL.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1352879-62-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H24N2O2 CVRZLTUKNRORBG-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-((4,5-dihydro-1h-imidazol-2-yl)methyl)-2-hydroxy-.beta.,.beta.,3,5-tetramethyl-benzeneethanol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.